Journal of the American Academy of Dermatology
Volume 83, Issue 6, Supplement, December 2020, Page AB31
15188 Clinical responses by self-reported PsA status at baseline among patients with moderate to severe psoriasis treated with guselkumab versus secukinumab: Week 48 results from the ECLIPSE study
References (0)
Cited by (0)
Commercial disclosure: This study was sponsored by Janssen Research & Development.
Copyright © 2020 Published by Mosby, Inc.